Compare Tilray Brands Inc (TLRY) vs UBS Group AG Registered Ordinary Shares (UBS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tilray Brands Inc vs UBS Group AG Registered Ordinary Shares — how do they compare? Tilray Brands Inc trades at $3.63 (market cap $530.54M), while UBS Group AG Registered Ordinary Shares trades at $47.72 (market cap $142.70B). The key difference: UBS Group AG Registered Ordinary Shares is far larger — about 269× Tilray Brands Inc's market cap, and UBS Group AG Registered Ordinary Shares pays a 2.34% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Tilray Brands Inc for 31 Days and UBS Group AG Registered Ordinary Shares for 0 Days on average.
| TLRY | UBS | |
|---|---|---|
Market Cap | $530.54M | $142.70B |
Volume | 9,099,075 | 2,096,090 |
Sector | Health | Financials |
52-Week High | $21.00 | $55.72 |
52-Week Low | $3.57 | $36.41 |
Typical Hold Time | 31 Days | 0 Days |
Enterprise Value | $684.46M | $314.41B |
Dividend Yield | — | 2.34% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TLRY trades at $3.715, down 1.72% on the day and near its 52-week low, reflecting persistent bearish technical momentum. The company reported revenue of $821.31M in 2025 but a substantial net loss of -$2.19B, with negative cash flow from operations. Recent quarters show consistent earnings misses versus expectations, though analyst consensus suggests a high price target of $65.01 amid mixed sentiment.
The outlook remains challenged by profitability issues and high debt, but potential catalysts include U.S. cannabis regulatory changes. Investment opportunities hinge on speculative regulatory shifts, while risks include ongoing losses, competitive pressures, and reliance on financing activities to sustain operations.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →About UBS Group AG Registered Ordinary Shares
UBS is a global financial services company focused on wealth management, investment banking, and asset management. It serves private, corporate, and institutional clients.
Read more on UBS →
